Join Discovery at the ISSX 2023 Annual Meeting at Booth 301! Schedule a meeting with our team today!
Join our speaking presentation with Dr. David Randle on Sept 12 at 2:15pm.
Gentest® In Vitro Preclinical Solutions at Discovery
This presentation will showcase the comprehensive portfolio of Gentest® In Vitro Preclinical Solutions at Discovery Life Sciences. The Gentest(R) brand now provides access to one of the world’s largest inventories of hepatocytes, tissue fractions, and recombinant enzymes, complemented by leading-edge service technologies. In this presentation, we will delve into the details of this unique innovation engine and its pivotal role in supporting ADME and toxicology scientists. By facilitating the generation of crucial data, our solutions empower the scientists to make informed decisions that significantly impact drug developments.
About the speaker:
David Randle, PhD
VP, Preclinical Services, Discovery Life Sciences
David received his PhD in Biochemistry from the University of Tennessee and performed post-doctoral studies at the University of California, San Francisco. He spent over 15 years at Corning Life Sciences developing label-free high-throughput cell-based and biochemical assays, as well as novel 3D cell culture applications before transitioning into the leadership of the Gentest business. Accompanying the acquisition of the business, David joined Discovery Life Sciences as the VP of Preclinical Services, and successfully combined the Gentest, IVAL and ReachBio businesses.
